Kwong Lung Enterprise (8916.TWO) Earnings Analysis

Kwong Lung Enterprise (8916.TWO) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS 0.17 TWD vs 0.12 TWD est (+41.7%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 17.84.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 8916.TWO next report earnings?

No confirmed upcoming earnings date is currently scheduled for 8916.TWO. This page updates as the calendar is published.

8916.TWO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-070.17 TWD0.12 TWD+41.7%Beat
2026-03-090.0996 TWD0.64 TWD-84.4%Miss
2025-08-070.67 TWD1.23 TWD-45.5%Miss
2025-03-110.49 TWD0.48 TWD+2.1%Beat
2024-11-070.91 TWD1.22 TWD-25.4%Miss
2024-08-081.62 TWD1.52 TWD+6.6%Beat

Beat rate: 3/6 (50%) over reported quarters with consensus data.

8916.TWO valuation and analyst view

Trailing P/E17.84
Trailing EPS2.286 TWD
Price / book1.30
Dividend yield8.60%
Market cap6.25B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Kwong Lung Enterprise (8916.TWO)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 8916.TWO. This page updates as the calendar is published.

Did 8916.TWO beat earnings last quarter?

In its 2026-05-07 report, 8916.TWO posted EPS of 0.17 TWD versus a 0.12 TWD estimate — a beat of 41.7%.

What is 8916.TWO's earnings track record?

Over the last 6 reported quarters with consensus data, 8916.TWO beat estimates 3 times (50%).

What is 8916.TWO's current P/E ratio and EPS?

8916.TWO trades at a trailing P/E of 17.84 on trailing EPS of 2.286478520278649 TWD.

What do analysts rate 8916.TWO?

8916.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.